SAFE or SORRY? Patient Safety Study of the Prevention of Adverse Patient Outcomes

NCT ID: NCT00365430

Last Updated: 2009-01-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

3000 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-09-30

Study Completion Date

2008-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of SAFE or SORRY? is to develop and test an evidence based inpatient safety program for the prevention of three frequently occuring adverse events: pressure ulcers, urinary tract infections and falls.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background Patients in hospitals and nursing homes are at risk for the development of, often preventable, somatic complications. However, preventive care is not always optimal. Although guidelines are available for many complications, compliance with the guidelines appears to be lacking. Besides general barriers that inhibit implementation, this non-compliance is also associated with the large number of guidelines competing for attention. As implementation of a guideline is time-consuming, organisations can never implement all available guidelines. Another problem is lack of feedback about performance using clear quality indicators and lack of a recognizable, unambiguous system for implementation.

Aim The aim of SAFE or SORRY? is to develop and test an evidence based inpatient safety program for the prevention of three frequently occuring adverse events: pressure ulcers, urinary tract infections and falls.

Participants Patients and nurses will be recruited from ten hospital wards and ten nursing home wards in the Netherlands. All nurses and all adult patients who are admitted for more than three days, will be asked for informed consent.

Method This study consists of two phases. In the first phase the program will be developed. The content of the program is based on the evidence based guidelines on pressure ulcers, urinary tract infections and falls. The program consists of a computerized registration and feedback system, an educational program for nurses and caregivers, and educational material for the patients.

In the second phase the program will be tested in a cluster randomised clinical trial. The program will be implemented on ten wards (5 hospital wards and 5 nursing home wards), i.e. the intervention group. The control group will continue to give care as usual.

Outcome measures Primary outcome measure: incidence of pressure ulcers, urinary tract infections and falls Secondary outcome measures: Utilization of preventive interventions and knowledge of nurses and caregivers regarding the complications and their prevention.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pressure Ulcer Urinary Tract Infection Accidental Falls

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

safety program

Education, patient involvement, tailored implementation and a computerized registration system

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients on participating wards admitted for more than three days
* all nurses on participating wards

Exclusion Criteria

* students on participating wards
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

ZonMw: The Netherlands Organisation for Health Research and Development

OTHER

Sponsor Role collaborator

Radboud University Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Radboud University Nijmegen Medical Centre

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Theo van Achterberg, PhD

Role: STUDY_DIRECTOR

Scientific Institute for Quality of Healthcare (IQ Healthcare), Radboud University Nijmegen Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Alysis Zorggroep lokatie Rijnstate

Arnhem, Gelderland, Netherlands

Site Status

Zorggroep Maas en Waal

Beneden-Leeuwen, Gelderland, Netherlands

Site Status

Canisius Wilhelmina Ziekenhuis

Nijmegen, Gelderland, Netherlands

Site Status

Radboud University Nijmegen Medical Center

Nijmegen, Gelderland, Netherlands

Site Status

Stichting De Waalboog

Nijmegen, Gelderland, Netherlands

Site Status

Zorggroep Zuid-Gelderland

Nijmegen, Gelderland, Netherlands

Site Status

Universitair Longcentrum Dekkerswald

Nijmegen, Gelderland, Netherlands

Site Status

Zorggroep Noord-Limburg Venlo

Venlo, Noord-Limburg, Netherlands

Site Status

Stichting SVVE De Archipel

Eindhoven, North Brabant, Netherlands

Site Status

Stichting De Riethorst Stromenland

Geertruidenberg, North Brabant, Netherlands

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

References

Explore related publications, articles, or registry entries linked to this study.

van Gaal BG, Schoonhoven L, Mintjes JA, Borm GF, Hulscher ME, Defloor T, Habets H, Voss A, Vloet LC, Koopmans RT, van Achterberg T. Fewer adverse events as a result of the SAFE or SORRY? programme in hospitals and nursing homes. part i: primary outcome of a cluster randomised trial. Int J Nurs Stud. 2011 Sep;48(9):1040-8. doi: 10.1016/j.ijnurstu.2011.02.017. Epub 2011 Mar 17.

Reference Type DERIVED
PMID: 21419411 (View on PubMed)

van Gaal BG, Schoonhoven L, Vloet LC, Mintjes JA, Borm GF, Koopmans RT, van Achterberg T. The effect of the SAFE or SORRY? programme on patient safety knowledge of nurses in hospitals and nursing homes: a cluster randomised trial. Int J Nurs Stud. 2010 Sep;47(9):1117-25. doi: 10.1016/j.ijnurstu.2010.02.001. Epub 2010 Mar 3.

Reference Type DERIVED
PMID: 20202633 (View on PubMed)

van Gaal BG, Schoonhoven L, Hulscher ME, Mintjes JA, Borm GF, Koopmans RT, van Achterberg T. The design of the SAFE or SORRY? study: a cluster randomised trial on the development and testing of an evidence based inpatient safety program for the prevention of adverse events. BMC Health Serv Res. 2009 Apr 1;9:58. doi: 10.1186/1472-6963-9-58.

Reference Type DERIVED
PMID: 19338655 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://www.wip.nl/free_content/richtlijnen/11111111blaaskatheterisatie.pdf

Guideline prevention urinary tract infection (The Netherlands)

http://www.verpleeghuisartsen.nl

Guideline Urinary Tracts Infections (The Netherlands)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

54010002

Identifier Type: -

Identifier Source: secondary_id

SoS245119

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Interrupting Self-Harm Study
NCT03550521 WITHDRAWN NA
Women's Wellbeing Study
NCT07195019 RECRUITING NA